| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
January 28, 2020
Beckman Coulter, a global leader in clinical diagnostics, today announced that its Access PCT assay has received FDA 510(k) clearance and is now available for sale in the United States. The...
January 7, 2020Beckman Coulter, a global leader in clinical diagnostics, announced today that South West London Pathology (SWLP) has implemented DxH 900 haematology analysers and the Early Sepsis Indicator...
-
October 29, 2019Beckman Coulter receives BARDA funding to develop algorithm to aid in the early detection of sepsis*
Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract...
-
October 21, 2019
Designed for mid-volume laboratories, Beckman Coulter’s DxH 690T offers industry-leading 93% first pass yield, and includes a 5-part differential and the Early Sepsis Indicator Brea, Calif., Oct...
October 9, 2019Beckman Coulter, a global leader in clinical diagnostics, announced today that the DxA 5000 total laboratory automation solution has received FDA 510(k) clearance and is now available for sale in...
